357 related articles for article (PubMed ID: 19214209)
1. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
Tank EM; True HL
PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
[TBL] [Abstract][Full Text] [Related]
2. Role of frameshift ubiquitin B protein in Alzheimer's disease.
Chen X; Petranovic D
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):300-13. PubMed ID: 27240056
[TBL] [Abstract][Full Text] [Related]
3. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.
Irmler M; Gentier RJ; Dennissen FJ; Schulz H; Bolle I; Hölter SM; Kallnik M; Cheng JJ; Klingenspor M; Rozman J; Ehrhardt N; Hermes DJ; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Meyer HE; Hopkins DA; Van Leeuwen FW; Beckers J
Acta Neuropathol; 2012 Aug; 124(2):187-97. PubMed ID: 22730000
[TBL] [Abstract][Full Text] [Related]
4. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.
van Leeuwen FW; Hol EM; Fischer DF
J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870
[TBL] [Abstract][Full Text] [Related]
5. Extended ubiquitin species are protein-based DUB inhibitors.
Krutauz D; Reis N; Nakasone MA; Siman P; Zhang D; Kirkpatrick DS; Gygi SP; Brik A; Fushman D; Glickman MH
Nat Chem Biol; 2014 Aug; 10(8):664-70. PubMed ID: 24997605
[TBL] [Abstract][Full Text] [Related]
6. Molecular misreading: the occurrence of frameshift proteins in different diseases.
van Leeuwen FW; Kros JM; Kamphorst W; van Schravendijk C; de Vos RA
Biochem Soc Trans; 2006 Nov; 34(Pt 5):738-42. PubMed ID: 17052186
[TBL] [Abstract][Full Text] [Related]
7. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates.
Verhoef LG; Heinen C; Selivanova A; Halff EF; Salomons FA; Dantuma NP
FASEB J; 2009 Jan; 23(1):123-33. PubMed ID: 18796559
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease-associated mutant ubiquitin (UBB
Wagh AR; Sulakshane P; Glickman MH
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194936. PubMed ID: 37075976
[TBL] [Abstract][Full Text] [Related]
9. Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae.
Kruegel U; Robison B; Dange T; Kahlert G; Delaney JR; Kotireddy S; Tsuchiya M; Tsuchiyama S; Murakami CJ; Schleit J; Sutphin G; Carr D; Tar K; Dittmar G; Kaeberlein M; Kennedy BK; Schmidt M
PLoS Genet; 2011 Sep; 7(9):e1002253. PubMed ID: 21931558
[TBL] [Abstract][Full Text] [Related]
10. Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.
Hong L; Huang HC; Jiang ZF
Neurol Res; 2014 Mar; 36(3):276-82. PubMed ID: 24512022
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model.
Verheijen BM; Stevens JAA; Gentier RJG; van 't Hekke CD; van den Hove DLA; Hermes DJHP; Steinbusch HWM; Ruijter JM; Grimm MOW; Haupenthal VJ; Annaert W; Hartmann T; van Leeuwen FW
Neurobiol Aging; 2018 Dec; 72():62-71. PubMed ID: 30216939
[TBL] [Abstract][Full Text] [Related]
12. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration.
Tan Z; Sun X; Hou FS; Oh HW; Hilgenberg LG; Hol EM; van Leeuwen FW; Smith MA; O'Dowd DK; Schreiber SS
Cell Death Differ; 2007 Oct; 14(10):1721-32. PubMed ID: 17571083
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.
Navarro-Yepes J; Anandhan A; Bradley E; Bohovych I; Yarabe B; de Jong A; Ovaa H; Zhou Y; Khalimonchuk O; Quintanilla-Vega B; Franco R
Mol Neurobiol; 2016 Oct; 53(8):5229-51. PubMed ID: 26409479
[TBL] [Abstract][Full Text] [Related]
15. Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.
Chadwick L; Gentle L; Strachan J; Layfield R
Neuropathol Appl Neurobiol; 2012 Apr; 38(2):118-31. PubMed ID: 22082077
[TBL] [Abstract][Full Text] [Related]
16. The Dose-Dependent Pleiotropic Effects of the UBB
Banasiak K; Szulc NA; Pokrzywa W
Front Mol Biosci; 2021; 8():650730. PubMed ID: 33842548
[TBL] [Abstract][Full Text] [Related]
17. Low levels of mutant ubiquitin are degraded by the proteasome in vivo.
van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF
J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of Ubp6 loss on drug sensitivities and yeast prion are due to depletion of the free ubiquitin pool.
Chernova TA; Allen KD; Wesoloski LM; Shanks JR; Chernoff YO; Wilkinson KD
J Biol Chem; 2003 Dec; 278(52):52102-15. PubMed ID: 14559899
[TBL] [Abstract][Full Text] [Related]
19. UBB
Chen X; Muñoz-Arellano AJ; Petranovic D
Aging (Albany NY); 2021 Nov; 13(21):23953-23980. PubMed ID: 34751669
[TBL] [Abstract][Full Text] [Related]
20. The Molecular Misreading of APP and UBB Induces a Humoral Immune Response in Alzheimer's Disease Patients with Diagnostic Ability.
Montero-Calle A; San Segundo-Acosta P; Garranzo-Asensio M; Rábano A; Barderas R
Mol Neurobiol; 2020 Feb; 57(2):1009-1020. PubMed ID: 31654319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
